Simple thromboplastin correction test

The simple thromboplastin correction test is mainly used to check the first stage of the endogenous coagulation system for obstacles. Since Bigg's thromboplastin generation test (TGT) has the disadvantages of labor, blood and time, Xu Fuyan and others first reported the simple thromboplastin generation test (STGT) and its correction test in 1965. It is an endogenous coagulation pathway, especially a corrective test for the diagnosis of hemophilia. When the result of the simple thromboplastin test is greater than 15 seconds, use normal human barium sulfate to adsorb plasma and normal human serum to correct the patient's suggested poor thromboplastin production. For example, use normal adsorbed plasma containing factors Ⅶ, Ⅷ, and Ⅺ, or normal serum containing factor Ⅸ, Ⅺ, and Ⅻ, or normal adsorbed serum containing factor Ⅺ, Ⅻ, and normal fresh plasma for correction tests to determine what is lacking clotting factor.